Introducing the Future of Organ Preservation

The VP.S ENCORE® is an innovative medical device designed to revolutionize organ preservation techniques. It offers a promising solution to the global organ shortage crisis by providing an alternative to traditional preservation methods, such as ice-filled coolers and expensive technologies. With pending patents, the VP.S ENCORE® has garnered significant attention, particularly with its Breakthrough Device Designation from the FDA, received in 2021.

This designation signifies the device's potential to address critical medical needs and highlights its importance in the field of organ transplantation. By streamlining communication between the company and regulatory authorities like the FDA, the Breakthrough Device Designation aims to accelerate the device's path to market.

Though the VP.S ENCORE® is still pending FDA approval, its promise in revolutionizing organ preservation and transplantation is undeniable, offering hope for patients awaiting life-saving organ transplants worldwide.

Note: The VP.S ENCORE® device has not yet been approved by the FDA

What sets the VP.S ENCORE® apart is its adaptability and versatility. It can be modified to extend the preservation of various organs and vascularized tissues, hinting at future applications in ex vivo therapies and organ banking. This versatility underscores its potential to significantly impact the donor pool, enhancing organ matching and potentially reducing instances of rejection, such as primary graft dysfunction.

Ease of Use

The VP.S ENCORE® system includes a single-use disposable element with a non-blood, nutrient-rich solution (perfusate), readily available at transplant centers. Engineered to withstand temperatures of up to 40ºC and cabin pressures of passenger aircraft, it ensures robust performance in diverse environments. Furthermore, its durable design facilitates easy transportation, with a fail-safe mechanism that reverts to standard static cooling if necessary.

Portable

The VP.S ENCORE® Device is engineered for convenient transport, housed within an outer casing similar in size to carry-on luggage. In contrast, competing technologies utilizing blood as the perfusate are larger and more cumbersome, often requiring specialized transport vehicles.

Left: VP.S ENCORE® Device

Right: Office Copier machine